PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

34 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ 1 ... 2 ... ▶▶ ▶▮
Alle Publikationen dieser Seite in den Korb legen
1.
Harada, M. et al.: Urea cycle modulation by combined SGLT2 inhibitors and metformin. BMC Med. 24:55 (2026)
2.
Klein, H.* et al.: How effective is rejoining a long-term weight loss program? The 5- and 10-year MRI-assessed Follow Interventions Trial (FIT) project. BMC Med. 24:121 (2026)
3.
Lai, L. et al.: Association of DNA methylation with hypertension and blood pressure: A 7-year longitudinal study from KORA F4/FF4. BMC Med. 24:125 (2026)
4.
Klein, H.* et al.: Visceral adipose tissue area and proportion provide distinct reflections of cardiometabolic outcomes in weight loss; pooled analysis of MRI-assessed CENTRAL and DIRECT PLUS dietary randomized controlled trials. BMC Med. 23:57 (2025)
5.
Klein, H.* et al.: Correction: Visceral adipose tissue area and proportion provide distinct reflections of cardiometabolic outcomes in weight loss; pooled analysis of MRI-assessed CENTRAL and DIRECT PLUS dietary randomized controlled trials. BMC Med. 23:92 (2025)
6.
Sehgal, R.* et al.: Adipose tissue-derived microRNAs as epigenetic modulators of type 2 diabetes. BMC Med. 23:678 (2025)
7.
Staude, B.* et al.: Association of specific microbiota taxa in the amniotic fluid at birth with severe acute and longer-term outcomes of very preterm infants: A prospective observational study. BMC Med. 23:431 (2025)
8.
Thews, O.* et al.: Physiological serum uric acid concentrations correlate with arterial stiffness in a sex-dependent manner. BMC Med. 23:356 (2025)
9.
Luo, H. et al.: Association of plasma proteomics with mortality in individuals with and without type 2 diabetes: Results from two population-based KORA cohort studies. BMC Med. 22:420 (2024)
10.
Van Rampelbergh, J.* et al.: First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetes: an exploratory analysis of immune biomarkers. BMC Med. 22:259 (2024)
11.
Wagner, R. et al.: Carrageenan and insulin resistance in humans: A randomised double-blind cross-over trial. BMC Med. 22:558 (2024)
12.
Zeng, F.* et al.: Gut microbiome features and metabolites in non-alcoholic fatty liver disease among community-dwelling middle-aged and older adults. BMC Med. 22:104 (2024)
13.
Fosse, V.* et al.: Recommendations for robust and reproducible preclinical research in personalised medicine. BMC Med. 21:14 (2023)
14.
Gill, D.* et al.: The citrate transporter SLC13A5 as a therapeutic target for kidney disease: Evidence from Mendelian randomization to inform drug development. BMC Med. 21:504 (2023)
15.
Lin, J. et al.: Proteomic profiling of longitudinal changes in kidney function among middle-aged and older men and women: The KORA S4/F4/FF4 study. BMC Med. 21:245 (2023)
16.
Rothwell, J.A.* et al.: Circulating amino acid levels and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition and UK Biobank cohorts. BMC Med. 21:80 (2023)
17.
Van Rampelbergh, J.* et al.: First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetes. BMC Med. 21:190 (2023)
18.
Yaskolka Meir, A.* et al.: The effect of polyphenols on DNA methylation-assessed biological age attenuation: The DIRECT PLUS randomized controlled trial. BMC Med. 21:364 (2023)
19.
Breeur, M.* et al.: Pan-cancer analysis of pre-diagnostic blood metabolite concentrations in the European Prospective Investigation into Cancer and Nutrition. BMC Med. 20:351 (2022)
20.
Freuer, D.* ; Linseisen, J. & Meisinger, C.*: Asthma and the risk of gastrointestinal disorders: A Mendelian randomization study. BMC Med. 20:82 (2022)
▮◀ ◀◀ 1 ... 2 ... ▶▶ ▶▮